These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17075035)

  • 21. Role of endothelium-derived hyperpolarising factor in acetylcholine-mediated vasodilatation in skin.
    Newton DJ; Davies J; Belch JJ; Khan F
    Int Angiol; 2013 Jun; 32(3):312-8. PubMed ID: 23711683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow-mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans.
    Kooijman M; Thijssen DH; de Groot PC; Bleeker MW; van Kuppevelt HJ; Green DJ; Rongen GA; Smits P; Hopman MT
    J Physiol; 2008 Feb; 586(4):1137-45. PubMed ID: 18096601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the endothelium in the hyperemic response to passive leg movement: looking beyond nitric oxide.
    Trinity JD; Kwon OS; Broxterman RM; Gifford JR; Kithas AC; Hydren JR; Jarrett CL; Shields KL; Bisconti AV; Park SH; Craig JC; Nelson AD; Morgan DE; Jessop JE; Bledsoe AD; Richardson RS
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H668-H678. PubMed ID: 33306447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide.
    Doshi SN; Naka KK; Payne N; Jones CJ; Ashton M; Lewis MJ; Goodfellow J
    Clin Sci (Lond); 2001 Dec; 101(6):629-35. PubMed ID: 11724650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of NO and EDHF in flow-induced vasodilation in isolated hamster cremasteric arterioles.
    Watanabe S; Yashiro Y; Mizuno R; Ohhashi T
    J Vasc Res; 2005; 42(2):137-47. PubMed ID: 15677873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of endothelium-derived hyperpolarizing factor and nitric oxide on endothelial function in femoral resistance arteries of spontaneously hypertensive rats.
    Mori Y; Ohyanagi M; Koida S; Ueda A; Ishiko K; Iwasaki T
    Hypertens Res; 2006 Mar; 29(3):187-95. PubMed ID: 16755154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients.
    Taddei S; Versari D; Cipriano A; Ghiadoni L; Galetta F; Franzoni F; Magagna A; Virdis A; Salvetti A
    J Am Coll Cardiol; 2006 Aug; 48(3):508-15. PubMed ID: 16875977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
    Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W
    Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide- and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9.
    Passauer J; Pistrosch F; Lässig G; Herbrig K; Büssemaker E; Gross P; Fleming I
    Kidney Int; 2005 May; 67(5):1907-12. PubMed ID: 15840038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
    Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
    Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced release of endothelium-derived hyperpolarizing factor in small coronary arteries from rats with congestive heart failure.
    Ueda A; Ohyanagi M; Koida S; Iwasaki T
    Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):615-21. PubMed ID: 16120187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogenous vasodilator pathways underlie flow-mediated dilation in men and women.
    Parker BA; Tschakovsky ME; Augeri AL; Polk DM; Thompson PD; Kiernan FJ
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1118-26. PubMed ID: 21642502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide contributes to cerebrovascular shear-mediated dilatation but not steady-state cerebrovascular reactivity to carbon dioxide.
    Hoiland RL; Caldwell HG; Carr JMJR; Howe CA; Stacey BS; Dawkins T; Wakeham DJ; Tremblay JC; Tymko MM; Patrician A; Smith KJ; Sekhon MS; MacLeod DB; Green DJ; Bailey DM; Ainslie PN
    J Physiol; 2022 Mar; 600(6):1385-1403. PubMed ID: 34904229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of endothelium-derived hyperpolarizing factor to exercise-induced vasodilation in health and hypercholesterolemia.
    Ozkor MA; Hayek SS; Rahman AM; Murrow JR; Kavtaradze N; Lin J; Manatunga A; Quyyumi AA
    Vasc Med; 2015 Feb; 20(1):14-22. PubMed ID: 25648989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in vascular nitric oxide and endothelium-derived hyperpolarizing factor bioavailability in blacks and whites.
    Ozkor MA; Rahman AM; Murrow JR; Kavtaradze N; Lin J; Manatunga A; Hayek S; Quyyumi AA
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1320-7. PubMed ID: 24675657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of endothelium-mediated vasodilator response in the rat hindlimb vasculature consecutive to chronic hypoxic stress: NO and EDHF involvement.
    Reboul C; Gibault A; Tanguy S; Dauzat M; Obert P
    Vascul Pharmacol; 2009; 51(2-3):154-61. PubMed ID: 19520187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of nitric oxide and prostaglandins, but not endothelial-derived hyperpolarizing factors, reduces blood flow and aerobic energy turnover in the exercising human leg.
    Mortensen SP; González-Alonso J; Damsgaard R; Saltin B; Hellsten Y
    J Physiol; 2007 Jun; 581(Pt 2):853-61. PubMed ID: 17347273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of endothelium-derived hyperpolarizing factor in the regulation of the uterine circulation in pregnant rats.
    Fulep EE; Vedernikov YP; Saade GR; Garfield RE
    Am J Obstet Gynecol; 2001 Sep; 185(3):638-42. PubMed ID: 11568792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia.
    Mullen MJ; Kharbanda RK; Cross J; Donald AE; Taylor M; Vallance P; Deanfield JE; MacAllister RJ
    Circ Res; 2001 Feb; 88(2):145-51. PubMed ID: 11157665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of arterial smooth muscle tone and geometry in the regulation of peripheral conduit artery mechanics by shear stress.
    Joannides R; Costentin A; Iacob M; Bakkali el-H; Richard MO; Thuillez C
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1025-31. PubMed ID: 11903308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.